Cargando…

CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson’s disease

Parkinson’s disease (PD) is a progressive neurodegenerative disease characterized by gradual loss of midbrain dopamine neurons, leading to impaired motor function. Preclinical studies have indicated cerebral dopamine neurotrophic factor (CDNF) and mesencephalic astrocyte-derived neurotrophic factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pakarinen, Emmi, Lindholm, Päivi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405524/ https://www.ncbi.nlm.nih.gov/pubmed/37555005 http://dx.doi.org/10.3389/fpsyt.2023.1188697

Ejemplares similares

CDNF and MANF regulate ER stress in a tissue-specific manner
por: Pakarinen, Emmi, et al.
Publicado: (2022)

Characterization of the Structural and Functional Determinants of MANF/CDNF in Drosophila In Vivo Model
por: Lindström, Riitta, et al.
Publicado: (2013)

A Comparative Analysis of the Molecular Features of MANF and CDNF
por: Norisada, Junpei, et al.
Publicado: (2016)

Trophic Factors in Inflammation and Regeneration: The Role of MANF and CDNF
por: Sousa-Victor, Pedro, et al.
Publicado: (2018)

Human-Specific Regulation of Neurotrophic Factors MANF and CDNF by microRNAs
por: Konovalova, Julia, et al.
Publicado: (2021)

CDNF Interacts with ER Chaperones and Requires UPR Sensors to Promote Neuronal Survival
por: Eesmaa, Ave, et al.
Publicado: (2022)

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Is Highly Expressed in Mouse Tissues With Metabolic Function
por: Danilova, Tatiana, et al.
Publicado: (2019)

MANF Ablation Causes Prolonged Activation of the UPR without Neurodegeneration in the Mouse Midbrain Dopamine System
por: Pakarinen, Emmi, et al.
Publicado: (2020)

Poststroke delivery of MANF promotes functional recovery in rats
por: Mätlik, Kert, et al.
Publicado: (2018)

CDNF Protein Therapy in Parkinson’s Disease
por: Huttunen, Henri J., et al.
Publicado: (2019)

Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson’s Disease
por: Garea-Rodríguez, Enrique, et al.
Publicado: (2016)

Characterization of CDNF-Secreting ARPE-19 Cell Clones for Encapsulated Cell Therapy
por: Galli, Emilia, et al.
Publicado: (2019)

Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington’s disease
por: Stepanova, P., et al.
Publicado: (2020)

Exploring the Conserved Role of MANF in the Unfolded Protein Response in Drosophila melanogaster
por: Lindström, Riitta, et al.
Publicado: (2016)

Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease
por: Bäck, Susanne, et al.
Publicado: (2013)

Deficiency of the ER-stress-regulator MANF triggers progressive outer hair cell death and hearing loss
por: Herranen, Anni, et al.
Publicado: (2020)

Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease
por: Stepanova, P., et al.
Publicado: (2023)

Secondary Pathology of the Thalamus after Focal Cortical Stroke in Rats is not Associated with Thermal or Mechanical Hypersensitivity and is Not Alleviated by Intra-Thalamic Post-Stroke Delivery of Recombinant CDNF or MANF
por: Anttila, Jenni E., et al.
Publicado: (2019)

CDNF rescues motor neurons in models of amyotrophic lateral sclerosis by targeting endoplasmic reticulum stress
por: De Lorenzo, Francesca, et al.
Publicado: (2023)

In vivo screening reveals interactions between Drosophila Manf and genes involved in the mitochondria and the ubiquinone synthesis pathway
por: Lindström, Riitta, et al.
Publicado: (2017)

Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action
por: Voutilainen, Merja H., et al.
Publicado: (2017)

Spatiotemporal Expression of MANF in the Developing Rat Brain
por: Wang, Haiping, et al.
Publicado: (2014)

Association between cerebral dopamine neurotrophic factor (CDNF) 2 polymorphisms and schizophrenia susceptibility and symptoms in the Han Chinese population
por: Yang, Yongfeng, et al.
Publicado: (2018)

Protection of dopamine neurons by CDNF and neurturin variant N4 against MPP(+) in dissociated cultures from rat mesencephalon
por: Jaumotte, Juliann D., et al.
Publicado: (2021)

MANF protects human pancreatic beta cells against stress-induced cell death
por: Hakonen, Elina, et al.
Publicado: (2018)

The Effect of RADA16-I and CDNF on Neurogenesis and Neuroprotection in Brain Ischemia-Reperfusion Injury
por: Liu, Xingyu, et al.
Publicado: (2022)

The cytoprotective protein MANF promotes neuronal survival independently from its role as a GRP78 cofactor
por: Eesmaa, Ave, et al.
Publicado: (2021)

Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D(3) Receptors in the Brain in vivo
por: Kiss, Béla, et al.
Publicado: (2022)

Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism
por: Lindholm, Päivi, et al.
Publicado: (2021)

Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
por: Sonnenschein, Susan F., et al.
Publicado: (2020)

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Elevates Stimulus-Evoked Release of Dopamine in Freely-Moving Rats
por: Renko, Juho-Matti, et al.
Publicado: (2018)

The Dopamine Hypothesis of Drug Addiction and Its Potential Therapeutic Value
por: Diana, Marco
Publicado: (2011)

Potential application of lithium in Parkinson's and other neurodegenerative diseases
por: Lazzara, Carol A., et al.
Publicado: (2015)

Systemic Administration of Orexin a Loaded Liposomes Potentiates Nucleus Accumbens Shell Dopamine Release by Sucrose Feeding
por: Lai, Francesco, et al.
Publicado: (2018)

Intrastriatally Infused Exogenous CDNF Is Endocytosed and Retrogradely Transported to Substantia Nigra
por: Mätlik, Kert, et al.
Publicado: (2017)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Cerebral Dopamine Neurotrophic Factor (CDNF) Has Neuroprotective Effects against Cerebral Ischemia That May Occur through the Endoplasmic Reticulum Stress Pathway
por: Zhang, Geng-Lin, et al.
Publicado: (2018)

No Influence of Dopamine System Gene Variations on Acute Effects of MDMA
por: Vizeli, Patrick, et al.
Publicado: (2019)

Neuroplastin Modulates Anti-inflammatory Effects of MANF
por: Yagi, Takuya, et al.
Publicado: (2020)

Magnetic resonance imaging of the dopamine system in schizophrenia – A scoping review
por: Schulz, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m1dik1alfvg34r3lelv5p3bsac